Stock Analiz

Metlife Inc. (MET) stock forecast and price target

Price $102.65 · data as of November 13, 2026

12-month price target

Average target$111.12
Upside / downside+8.3%
Analysts16
ConsensusBuy
Low $84.00Average $111.12High $131.00

Gold marker: average target · white marker: today’s price ($102.65)

Analyst ratings

Strong buy 5Buy 8Hold 4Sell 0Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$10.23+15.9%$79.5B
Next fiscal year
ends December 31, 2027
$11.18+9.3%$83.0B
Next quarter
ends December 31, 2026
$2.63+5.5%$20.5B
Quarter after
ends March 31, 2027
$2.58+6.7%$20.5B

Consensus of the analysts covering Metlife, updated daily. In the last 30 days 9 estimates were raised and 2 lowered.

Our model vs. Wall Street

Analysts see 8.3% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Metlife’s intrinsic value about 3% above today’s market value, and it scores 2.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Metlife stock price target?

The average 12-month target from 16 analysts is $111.12, 8.3% above the current price of $102.65 Targets range from $84.00 to $131.00.

Is Metlife a buy according to analysts?

The consensus rating is “Buy” (5 strong buy, 8 buy, 4 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Metlife expected to earn?

Analysts expect EPS of $10.23 for the fiscal year ending December 31, 2026 and $11.18 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.